| pubmed-article:21266808 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0546837 | lld:lifeskim |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0016360 | lld:lifeskim |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0746319 | lld:lifeskim |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:21266808 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:21266808 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:21266808 | pubmed:dateCreated | 2011-1-26 | lld:pubmed |
| pubmed-article:21266808 | pubmed:abstractText | Despite improvements in the surgical management of esophageal cancer, the prognosis of patients with lymph node metastases is still unsatisfactory. Recently, survival benefit of neoadjuvant or induction chemotherapy for patients with esophageal cancer has been highlighted. | lld:pubmed |
| pubmed-article:21266808 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21266808 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21266808 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21266808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21266808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21266808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21266808 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21266808 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21266808 | pubmed:issn | 1421-9867 | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:MiyamotoYujiY | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:WatanabeMasay... | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:BabaHideoH | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:IwatsukiMasaa... | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:HayashiNaokoN | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:BabaYoshifumi... | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:NagaiYoheiY | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:KurashigeJunj... | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:KarashimaRyui... | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:IwagamiShiroS | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:HiyoshiYukiha... | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:SaitoSeiyaS | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:ImamuraYuY | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:SatoNobutakaN | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:HirashimaKota... | lld:pubmed |
| pubmed-article:21266808 | pubmed:author | pubmed-author:KinoshitaKuic... | lld:pubmed |
| pubmed-article:21266808 | pubmed:copyrightInfo | Copyright © 2011 S. Karger AG, Basel. | lld:pubmed |
| pubmed-article:21266808 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21266808 | pubmed:volume | 83 | lld:pubmed |
| pubmed-article:21266808 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21266808 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21266808 | pubmed:pagination | 146-52 | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:meshHeading | pubmed-meshheading:21266808... | lld:pubmed |
| pubmed-article:21266808 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21266808 | pubmed:articleTitle | Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil for patients with node-positive esophageal cancer. | lld:pubmed |
| pubmed-article:21266808 | pubmed:affiliation | Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan. | lld:pubmed |
| pubmed-article:21266808 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21266808 | pubmed:publicationType | Review | lld:pubmed |
